KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)

被引：0
|
作者：
Berchuck, A. [1 ]
van der Baan, F. H. [2 ]
Johnatty, S. E. [3 ]
Chenevix-Trench, G. [4 ]
Pharoah, P. D. P. [5 ]
Rookus, M. A. [2 ]
Goode, E. [6 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Netherlands Canc Inst, Amsterdam, Netherlands
[3] Dept Genet, Brisbane, Qld, Australia
[4] Queensland Inst Med Res, Brisbane, Qld, Australia
[5] Univ Cambridge, Cambridge, England
[6] Mayo Clin, Rochester, MN USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 137卷
关键词：
D O I：
10.1016/j.ygyno.2015.01.062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
60
引用
收藏
页码：26 / 27
页数：3
相关论文
共 50 条
  • [21] Association of Type and Location of BRCA1 and BRCA2 Mutations With Risk of Breast and Ovarian Cancer
    Rebbeck, Timothy R.
    Mitra, Nandita
    Wan, Fei
    Sinilnikova, Olga M.
    Healey, Sue
    McGuffog, Lesley
    Mazoyer, Sylvie
    Chenevix-Trench, Georgia
    Easton, Douglas F.
    Antoniou, Antonis C.
    Nathanson, Katherine L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (13): : 1347 - 1361
  • [22] BRCA1 and BRCA2 Mutations in Ovarian Cancer Reply
    Zhang, Wei
    Yang, Da
    Sood, Anil K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (04): : 360 - 361
  • [23] BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
    Welcsh, PL
    King, MC
    HUMAN MOLECULAR GENETICS, 2001, 10 (07) : 705 - 713
  • [24] Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
    O'Mahony, Denise G.
    Ramus, Susan J.
    Southey, Melissa C.
    Meagher, Nicola S.
    Hadjisavvas, Andreas
    John, Esther M.
    Hamann, Ute
    Imyanitov, Evgeny N.
    Andrulis, Irene L.
    Sharma, Priyanka
    Daly, Mary B.
    Hake, Christopher R.
    Weitzel, Jeffrey N.
    Jakubowska, Anna
    Godwin, Andrew K.
    Arason, Adalgeir
    Bane, Anita
    Simard, Jacques
    Soucy, Penny
    Caligo, Maria A.
    Mai, Phuong L.
    Claes, Kathleen B. M.
    Teixeira, Manuel R.
    Chung, Wendy K.
    Lazaro, Conxi
    Hulick, Peter J.
    Toland, Amanda E.
    Pedersen, Inge Sokilde
    Neuhausen, Susan L.
    Vega, Ana
    de la Hoya, Miguel
    Nevanlinna, Heli
    Dhawan, Mallika
    Zampiga, Valentina
    Danesi, Rita
    Varesco, Liliana
    Gismondi, Viviana
    Vellone, Valerio Gaetano
    James, Paul A.
    Janavicius, Ramunas
    Nikitina-Zake, Liene
    Nielsen, Finn Cilius
    van Overeem Hansen, Thomas
    Pejovic, Tanja
    Borg, Ake
    Rantala, Johanna
    Offit, Kenneth
    Montagna, Marco
    Nathanson, Katherine L.
    Domchek, Susan M.
    BRITISH JOURNAL OF CANCER, 2023, 128 (12) : 2283 - 2294
  • [25] BRCA1 and BRCA2 as ovarian cancer susceptibility genes
    Sowter, HM
    Ashworth, A
    CARCINOGENESIS, 2005, 26 (10) : 1651 - 1656
  • [26] Missense Polymorphisms in BRCA1 and BRCA2 and Risk of Breast and Ovarian Cancer
    Dombernowsky, Sarah Louise
    Weischer, Maren
    Freiberg, Jacob Johannes
    Bojesen, Stig Egil
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge Gronne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (08) : 2339 - 2342
  • [27] Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
    Denise G. O’Mahony
    Susan J. Ramus
    Melissa C. Southey
    Nicola S. Meagher
    Andreas Hadjisavvas
    Esther M. John
    Ute Hamann
    Evgeny N. Imyanitov
    Irene L. Andrulis
    Priyanka Sharma
    Mary B. Daly
    Christopher R. Hake
    Jeffrey N. Weitzel
    Anna Jakubowska
    Andrew K. Godwin
    Adalgeir Arason
    Anita Bane
    Jacques Simard
    Penny Soucy
    Maria A. Caligo
    Phuong L. Mai
    Kathleen B. M. Claes
    Manuel R. Teixeira
    Wendy K. Chung
    Conxi Lazaro
    Peter J. Hulick
    Amanda E. Toland
    Inge Sokilde Pedersen
    Susan L. Neuhausen
    Ana Vega
    Miguel de la Hoya
    Heli Nevanlinna
    Mallika Dhawan
    Valentina Zampiga
    Rita Danesi
    Liliana Varesco
    Viviana Gismondi
    Valerio Gaetano Vellone
    Paul A. James
    Ramunas Janavicius
    Liene Nikitina-Zake
    Finn Cilius Nielsen
    Thomas van Overeem Hansen
    Tanja Pejovic
    Ake Borg
    Johanna Rantala
    Kenneth Offit
    Marco Montagna
    Katherine L. Nathanson
    Susan M. Domchek
    British Journal of Cancer, 2023, 128 : 2283 - 2294
  • [28] Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
    Silvestri, Valentina
    Barrowdale, Daniel
    Mulligan, Anna Marie
    Neuhausen, Susan L.
    Fox, Stephen
    Karlan, Beth Y.
    Mitchell, Gillian
    James, Paul
    Thull, Darcy L.
    Zorn, Kristin K.
    Carter, Natalie J.
    Nathanson, Katherine L.
    Dornchek, Susan M.
    Rebbeck, Timothy R.
    Ramus, Susan J.
    Nussbaum, Robert L.
    Olopade, Olufunrnilayo I.
    Rantala, Johanna
    Yoon, Sook-Yee
    Caligo, Maria A.
    Spugnesi, Laura
    Bojesen, Anders
    Pedersen, Inge Sokilde
    Thomassen, Muds
    Jensen, Uffe Birk
    Toland, Amanda Ewart
    Senter, Leigha
    Andrulis, Irene L.
    Glendon, Gord
    Hulick, Peter J.
    Irnyanitov, Evgeny N.
    Greene, Mark H.
    Mai, Phuong L.
    Singer, Christian F.
    Rappaport-Fuerhauser, Christine
    Kramer, Gero
    Vijai, Joseph
    Offit, Kenneth
    Robson, Mark
    Lincoln, Anne
    Jacobs, Lauren
    Machackova, Eva
    Foretova, Lenka
    Navratilova, Marie
    Vasickova, Petra
    Couch, Fergus J.
    Hallberg, Emily
    Ruddy, Kathryn J.
    Sharma, Priyanka
    Kim, Sung-Won
    BREAST CANCER RESEARCH, 2016, 18
  • [29] BRCA1 and BRCA2 mutations in ovarian cancer patients from China: Association of ethnic-specific mutations in BRCA1 with an increased risk of ovarian cancer
    Shi, Tingyan
    Wang, Pan
    Xie, Caixia
    Yin, Sheng
    Shi, Di
    Wei, Congchong
    Tang, Wenbin
    Jiang, Rong
    Cheng, Xi
    Wei, Qingyi
    Wang, Qing
    Zang, Rongyu
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2
    Valentina Silvestri
    Daniel Barrowdale
    Anna Marie Mulligan
    Susan L. Neuhausen
    Stephen Fox
    Beth Y. Karlan
    Gillian Mitchell
    Paul James
    Darcy L. Thull
    Kristin K. Zorn
    Natalie J. Carter
    Katherine L. Nathanson
    Susan M. Domchek
    Timothy R. Rebbeck
    Susan J. Ramus
    Robert L. Nussbaum
    Olufunmilayo I. Olopade
    Johanna Rantala
    Sook-Yee Yoon
    Maria A. Caligo
    Laura Spugnesi
    Anders Bojesen
    Inge Sokilde Pedersen
    Mads Thomassen
    Uffe Birk Jensen
    Amanda Ewart Toland
    Leigha Senter
    Irene L. Andrulis
    Gord Glendon
    Peter J. Hulick
    Evgeny N. Imyanitov
    Mark H. Greene
    Phuong L. Mai
    Christian F. Singer
    Christine Rappaport-Fuerhauser
    Gero Kramer
    Joseph Vijai
    Kenneth Offit
    Mark Robson
    Anne Lincoln
    Lauren Jacobs
    Eva Machackova
    Lenka Foretova
    Marie Navratilova
    Petra Vasickova
    Fergus J. Couch
    Emily Hallberg
    Kathryn J. Ruddy
    Priyanka Sharma
    Sung-Won Kim
    Breast Cancer Research, 18
12345